📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split
55%
• 50-day avg $0.50 below $1 exchange minimum
💹 Market Data
Market Cap$26.02M
Shares Outstanding79.07M
FloatN/A
Cash$11.34M
Debt$2.15M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 97.8% shares (2025Q4 vs prior)
1 institutional holders · 2.3K shares
#1
UBS Group AG
2.3K shares
📉 Short Interest
Short Interest31.6K
Days to Cover3.1
% of FloatN/A
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for NAMI
📊 NAMI FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NAMI Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.